The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
A new teacher has been hailed a hero after she intervened when a student opened fire in a school killing a girl and injuring four others.
The public love him but The X Factor judges seem shocked the Essex crooner has lasted three weeks on the live shows.
Rumours are swirling comedian Russell Brand is considering running for Boris Johnson's job.